Exostatics Pharmaceuticals S.L. is a biotech company, spin-off from the University of Bordeaux (France). The company has developed a patented technology based on synthetic chemosensors for the efficient isolation of exosomes and other circulating microvesicles from biological fluids (urine, plasma, etc.) for use in the diagnosis and prognosis of diseases. The patented compound has been validated in a proof of concept with urine and plasma samples for the detection of nephropathies, obtaining promising results in the uptake of these extracellular vesicles. By not targeting a specific biomarker and with a simpler laboratory process which preserves the integrity of exosomes, we provide a broader set of applications both for diagnostic and therapeutic purposes, across multiple health conditions.